Mycobacterium leprae antigen-specific CD4+ T cell activation

This term refers to the process by which CD4+ T lymphocytes recognize and are activated by antigens derived from Mycobacterium leprae, the causative agent of leprosy. The activation typically results in proliferation and cytokine secretion (notably IFN-γ, IL-2, and TNF-α), driving an immune response capable of limiting bacterial replication and dissemination[4]. The quality of this response is closely correlated with clinical outcome in leprosy, with robust Th1-dominated responses conferring protection and weaker or suppressive T regulatory responses (marked by CTLA-4 or FoxP3 expression) contributing to persistent or disseminated infection[2][7]. Unlike classical molecular targets, this is not a unique protein or receptor but describes a complex immunological event involving antigen presentation, T cell receptor signaling, and downstream effector functions.

Other names

leprosy antigen-specific Th1 cell responseCD4 T cell response to M. leprae

Enhancement or suppression of T cell activation (e.g., through immune checkpoint modulation[2])\nIndirect (Drugs for leprosy, such as dapsone, rifampicin, clofazimine, act on bacteria, not this target directly)